You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gene Editing

Showing 1 - 25 of 5,899
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gene Editing as a Therapeutic Approach for Rett Syndrome

Recruiting
  • Rett Syndrome
  • Gene editing in vitro
  • Siena, Italy
    University of Siena
Feb 13, 2023

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Retinitis Pigmentosa Trial (ZVS203e)

    Not yet recruiting
    • Retinitis Pigmentosa
    • (no location specified)
    Mar 27, 2023

    Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)

    Completed
    • Viral Keratitis
    • +3 more
    • BD111 Adult single group Dose
    • Shanghai, Shanghai, China
      Eye & Ent Hospital of Fudan University
    Aug 20, 2022

    Phenylketonurias, PAH Deficiency, Phenylketonuria Trial in United States (HMI-103)

    Recruiting
    • Phenylketonurias
    • +2 more
    • Orange, California
    • +5 more
    Oct 26, 2022

    MPS I Trial in Oakland (SB-318)

    Terminated
    Has Results
    • MPS I
    • SB-318
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Jan 6, 2023

    Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)

    Terminated
    Has Results
    • Mucopolysaccharidosis II
    • MPS II
    • SB-913
    • Oakland, California
    • +4 more
    Oct 21, 2022

    Hemophilia B Trial in Washington (SB-FIX)

    Terminated
    • Hemophilia B
    • SB-FIX
    • Washington, District of Columbia
      Georgetown University Medical Center
    Mar 8, 2022

    (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

    Active, not recruiting
    • Hemophilia B
    • +2 more
    • SB-318
    • +2 more
    • Oakland, California
    • +4 more
    Jan 30, 2023

    Exploiting Epigenome Editing in Kabuki Syndrome:New Route

    Completed
    • Kabuki Syndrome 1
    • Intervention on primary cultured cells
    • Montpellier, Herault, France
      Arnaud de villeneuve Hospital
    Nov 30, 2020

    Duchenne Muscular Dystrophy Trial in Worcester (CRD-TMH-001)

    Enrolling by invitation
    • Duchenne Muscular Dystrophy
    • Worcester, Massachusetts
      UMass Chan Medical School
    Aug 22, 2022

    Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration(nAMD)
    • HG202
    • Shanghai, Shanghai, China
    • +1 more
    Sep 4, 2023

    Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia Trial in Auckland,

    Recruiting
    • Heterozygous Familial Hypercholesterolemia
    • +2 more
    • Auckland, New Zealand
    • +1 more
    Aug 4, 2022

    Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

    Not yet recruiting
    • Sickle Cell Disease
    • Interview
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Mar 30, 2023

    Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • CTX131
    • Nashville, Tennessee
      Research Site 1
    Mar 21, 2023

    Natural History of Autosomal Dominant Hearing Loss

    Recruiting
    • Hearing Loss
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 12, 2022

      B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)

      Not yet recruiting
      • B-cell Lymphoma
      • +7 more
      • CTX112
      • (no location specified)
      Dec 12, 2022

      B-cell Lymphoma Trial in Hangzhou (PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells)

      Active, not recruiting
      • B-cell Lymphoma
      • PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, Zhejiang University School of Med
      Sep 28, 2022

      Gastrointestinal Epithelial Cancer, Gastrointestinal Tumors, Cancer of Gastrointestinal Tract Trial in Minneapolis

      Recruiting
      • Gastrointestinal Epithelial Cancer
      • +10 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Aug 20, 2021

      Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

      Active, not recruiting
      • Leber Congenital Amaurosis 10
      • +6 more
      • Miami, Florida
      • +4 more
      Dec 2, 2022

      Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated

      Not yet recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia (AML)
      • Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
      • Gemtuzumab Ozogamicin
      • Dresden, Germany
      • +1 more
      Dec 20, 2022

      Examining Knowledge, Attitudes, and Beliefs of Sickle Cell

      Completed
      • Sickle Cell Disease
        • Bethesda, Maryland
          National Human Genome Research Institute (NHGRI)
        Feb 5, 2021

        Major Depression Trial in Montpêllier (Blood sample for genetic purpose)

        Completed
        • Major Depression
        • Blood sample for genetic purpose
        • Montpêllier, France
          University Hospital
        Dec 21, 2021

        Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

        Not yet recruiting
        • Leukemia, Myeloid, Acute
        • CD33KO-HSPC; CART33
        • (no location specified)
        Jul 13, 2023

        SCD Curative Therapies

        Not yet recruiting
        • Sickle Cell Disease
        • +3 more
          • Washington, District of Columbia
          • +4 more
          Jun 28, 2022